OLAIolanzapineoral olanzapineschizophreniaFrench National Agency for Medicinespublic psychiatric hospital
…Background and Importance Long-acting injectable olanzapine (OLAI) is prescribed to stabilised schizophrenia patients previously …
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 601–660 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Sulfasalazine6Tisagenlecleucel6Zonisamide6erlotinib6hydromorphone6oxcarbazepine6Botulinum Toxin A6Calcineurin inhibitors6IL-76MMAE6PD-1 inhibitors6PLEX6Saline6Tezacaftor6abiraterone6anticoagulant6antihypertensive medications6dexketoprofen6oral steroids6phenytoin6sodium bicarbonate6Baclofen6Fluoroquinolone6Itraconazole6PPI6PRAME6Rapamycin6antiseizure medications6mephedrone6n-butyl cyanoacrylate6renin-angiotensin system inhibitors6Beta blocker6Entecavir6Oral corticosteroids6Valganciclovir6anti-seizure medications6cabotegravir/rilpivirine6citalopram6dextran sulfate sodium6penicillins6stimulants6teicoplanin6HRT5Treprostinil5Glimepiride5Orlistat5NKTR-2555Emicizumab5Efgartigimod5Sarilumab5Etrasimod5CAB-LA5D-Dimer5GDF-155TMZ5TAF5Darolutamide5ESPB5Marijuana53TC5
Articles mentioning drugs
10,506 articles · page 136 of 876morphinedexketoprofenparacetamolomeprazoletertiary care hospital
…hine, omeprazole and dexketoprofen. Justification rates varied: morphine 1% ampoules (54.54%), paracetamol 1 g tablets (31.43%), omepraz…
amitriptyline
…s showed faster drug release. The tablets containing commercial amitriptyline tablets showed a slower dissolution profile compared to the equ…
AmoxicillinMycophenolate mofetilValganciclovirErythromycinLinezolidAzithromycinAmoxicillin–clavulanic acidpaediatrics
…armacopoeia.Results Seven out of 13 formulations were selected: Amoxicillin 250 mg/5 mL, Amoxicillin–clavulanic acid 100 mg/mL–12.5 mg/mL, …
piflufolastatenzalutamideapalutamidecholineprostate cancerradical prostatectomycurative radiotherapyStereotactic Body Radiation TherapyCentral Pharmacy and Therapeutics Commission
…progression, persistence, or recurrence and were candidates for piflufolastat PET per Central Pharmacy and Therapeutics Commission protocol. …
amoxicillinlevofloxacinsulfamethoxazole/trimethoprimcotrimoxazolerifampicinapixabanosteomyelitisendocarditisabscesseslong-term antibiotic therapies+2 more
…re sulfamethoxazole/trimethoprim (24%), levofloxacin (20%), and amoxicillin (19%). A total of 21 pharmaceutical interventions (PIs) were pe…
FenfluraminecannabidiolLennox–Gastaut syndromeDravet syndrometertiary children’s hospitalLGSDS
…nd epileptic encephalopathies with limited therapeutic options. Fenfluramine has shown efficacy in DS and LGS, but evidence in other epilept…
evolocumabalirocumabPCSK9iezetimibebempedoic acidhypercholesterolaemiatertiary care hospital
…s with hypercholesterolaemia treated with PCSK9i (alirocumab or evolocumab).To assess the acceptance rate of the interventions.Material an…
bevacizumabTAStrifluridine/tipiracilBEVColorectal cancermCRCEastern Cooperative Oncology Group
…remains uncertain.Therapy with trifluridine/tipiracil (TAS) and bevacizumab (TAS+BEV) has been evaluated in phase III SUNLIGHT trial, demon…
secukinumabadalimumabIL-17Hidradenitis suppurativa (HS)secondary-level hospital
…ey role in HS pathophysiology, making IL-17 inhibitors, such as secukinumab, a therapeutic option.Aim and Objectives To assess the effectiv…
meropenemOXA48CarbapenemsVIMWorld Health Organisationsecondary care hospital
…nt de-escalation, which means 32 (39%) completed treatment with meropenem even though a narrower-spectrum antibiotic was effective.Conclu…
risankizumabvedolizumabinfliximabadalimumabIL-23 inhibitorsrefractory inflammatory bowel diseaseCrohn’s diseaseulcerative colitisinflammatory bowel diseaseperianal disease
…re recorded. At the end of follow-up, two patients continued on risankizumab monotherapy, while three maintained the combination therapy.Con…